%X A safe and effective vaginal microbicide could substantially reduce HIV acquisition for women. Consistent gel use is, however, of great importance to ensure continued protection against HIV infection, even with a safe and effective microbicide. We assessed the long-term correlates of consistent gel use in the MDP 301 clinical trial among HIV-negative women in sero-discordant couples in south-west Uganda.
%O © 2013 Abaasa et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  
PMCID: PMC3564905
%J Trials
%A A Abaasa
%A A Crook
%A M Gafos
%A Z Anywaine
%A J Levin
%A S Wandiembe
%A A Nanoo
%A A Nunn
%A S McCormack
%A R Hayes
%A A Kamali
%L discovery1418537
%V 14
%K Administration, Intravaginal, Adolescent, Adult, Age Factors, Anti-Infective Agents, Local, Female, HIV Infections, HIV Seronegativity, HIV Seropositivity, HIV-1, Housing, Humans, Likelihood Functions, Logistic Models, Male, Medication Adherence, Multivariate Analysis, Naphthalenesulfonates, Odds Ratio, Polymers, Pregnancy, Risk Factors, Rural Health, Sexual Partners, Socioeconomic Factors, Time Factors, Treatment Outcome, Uganda, Vaginal Creams, Foams, and Jellies, Young Adult
%T Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda
%C England
%D 2013
%P -